19 December 2025
Latham & Watkins Advises on Medline’s Upsized Landmark US$7.2 Billion IPO
Advising firms
Deal team
37 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Jason Licht Lead | Latham & Watkins LLP | Partner | Capital Markets | Not stated |
| Patrick Shannon Lead | Latham & Watkins LLP | Partner | Capital Markets | Not stated |
| Cathy Birkeland Lead | Latham & Watkins LLP | Partner | Capital Markets | Not stated |
| Christopher Cronin | Latham & Watkins LLP | Counsel | Capital Markets | Not stated |
| Ben Winnett | Latham & Watkins LLP | Associate | Capital Markets | Not stated |
| Chelsea Carlson | Latham & Watkins LLP | Associate | Capital Markets | Not stated |
| Caroline Hughes | Latham & Watkins LLP | Associate | Capital Markets | Not stated |
| Janani Hariharan | Latham & Watkins LLP | Associate | Capital Markets | Not stated |
| David Della Rocca | Latham & Watkins LLP | Partner | benefits | Not stated |
| Marysia Mullen | Latham & Watkins LLP | Counsel | benefits | Not stated |
| Ellie Graham | Latham & Watkins LLP | Associate | benefits | Not stated |
| Andrea Ramezan-Jackson | Latham & Watkins LLP | Partner | tax | Not stated |
| Christina McLeod | Latham & Watkins LLP | Associate | tax | Not stated |
| Nolon Blaylock | Latham & Watkins LLP | Associate | tax | Not stated |
| Ben Haas | Latham & Watkins LLP | Partner | FDA regulatory | Not stated |
| Jennifer Bragg | Latham & Watkins LLP | Partner | FDA regulatory | Not stated |
| Amy Speros | Latham & Watkins LLP | Counsel | FDA regulatory | Not stated |
| Hannah Chi | Latham & Watkins LLP | Associate | FDA regulatory | Not stated |
| Eveline Van Keymeulen | Latham & Watkins LLP | Partner | ex-US regulatory | Not stated |
| Jeanne Fabre | Latham & Watkins LLP | Associate | ex-US regulatory | Not stated |
| Jason Caron | Latham & Watkins LLP | Partner | healthcare regulatory | Not stated |
| Betty Pang | Latham & Watkins LLP | Partner | healthcare regulatory | Not stated |
| Chad Leiper | Latham & Watkins LLP | Associate | healthcare regulatory | Not stated |
| Claire Jensen | Latham & Watkins LLP | Associate | healthcare regulatory | Not stated |
| Heather Deixler | Latham & Watkins LLP | Partner | data privacy and cybersecurity | Not stated |
| Kieran Dickinson | Latham & Watkins LLP | Counsel | intellectual property | Not stated |
| Caroline Toman Lammon | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Joshua Marnitz | Latham & Watkins LLP | Partner | environmental | Not stated |
| Nolan Fargo | Latham & Watkins LLP | Associate | environmental | Not stated |
| Ruchi Gill | Latham & Watkins LLP | Counsel | compliance | Not stated |
| Katherine Sawyer | Latham & Watkins LLP | Counsel | compliance | Not stated |
| Faiza Hasan | Latham & Watkins LLP | Associate | compliance | Not stated |
| Monica Calce | Latham & Watkins LLP | Associate | compliance | Not stated |
| Gail Neely | Latham & Watkins LLP | Partner | FINRA and regulatory | Not stated |
| Marta Talarek | Latham & Watkins LLP | Other | corporate | Not stated |
| Alex Cohen | Latham & Watkins LLP | Partner | securities laws | Not stated |
| Joel Trotter | Latham & Watkins LLP | Partner | securities laws | Not stated |
34 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 7.20bn (US$7.2 Billion)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- Medline Inc. (Issuer)